An Israeli startup has developed the world’s first saliva-based pregnancy test, which will be sold internationally starting in 2023.
Salignostics provides rapid tests without the need for a urine or blood sample. The test – called the SaliStick – delivers accurate results in no more than 10 minutes.
It will be sold in Europe, South Africa, and in the United Arab Emirates.
“Saliva is the key to rapid diagnostics for a variety of medical reasons. It is the only non-invasive, easy, and hygienic means to detect hormones, viruses, and even diseases,” said Prof Aaron Palmon, Co-founder of Salignostics.
“With SaliStick, we leverage the powerful diagnostics abilities we have been able to create from analyzing saliva. This product completely removes the need for blood and urine samples when testing for pregnancy.”
The company has established a new manufacturing facility in the Lavon Industrial Zone, in Northern Israel, with a monthly production capacity of one million units.
Salignostics was founded in 2016 by a team of researchers at the Hebrew University of Jerusalem.
After years of scientific research in saliva, the founders developed user-friendly products to accurately detect Covid-19, cardiac risk, malaria, and other diseases.
The company has raised a total of $16 million to date, and is now raising additional funding to support sales, marketing, and R&D.